SCHEMBL4879813

SCHEMBL4879813

N#CC(=Cc1ccc(Cl)cc1)C(N)=S

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.70
ALDH1A1 P00352 9/20 0.70
GAA P10253 3/20 0.70
HTT P42858 1/20 0.70
ATM Q13315 1/20 0.70
KMT2A Q03164 8/20 0.64
TDP1 Q9NUW8 6/20 0.64
KDM4E B2RXH2 6/20 0.64
HPGD P15428 6/20 0.64
MEN1 O00255 7/20 0.61
RECQL P46063 4/20 0.61
BLM P54132 4/20 0.61
MAPK1 P28482 4/20 0.61
NPSR1 Q6W5P4 3/20 0.61
PMP22 Q01453 3/20 0.61
CYP1A2 P05177 3/20 0.61
CYP3A4 P08684 3/20 0.61
TSHR P16473 3/20 0.61
HIF1A Q16665 3/20 0.61
HSD17B10 Q99714 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688074 0.95 MAPT (0.64) MAPTALDH1A1GAAHTTATM
SCHEMBL4878079 0.82 MAPT (0.70) MAPTALDH1A1GAAHTTATM
SCHEMBL27294438 0.82 MCL1 (0.69) MAPTALDH1A1GAAKMT2ATDP1
SCHEMBL32688435 0.82 MAPT (0.70) MAPTALDH1A1GAAHTTATM
SCHEMBL4879772 0.82 MAPT (0.70) MAPTALDH1A1GAAHTTATM
SCHEMBL10386359 0.82 MCL1 (0.69) MAPTALDH1A1GAAKMT2ATDP1
SCHEMBL19928344 0.81 MAPT (0.69) MAPTALDH1A1GAAHTTATM
SCHEMBL8483397 0.81 ALDH1A1 (0.65) MAPTALDH1A1GAAHTTATM
SCHEMBL32687992 0.81 ALDH1A1 (0.52) MAPTALDH1A1GAAHTTATM
SCHEMBL32688162 0.79 MAPT (0.66) MAPTALDH1A1GAAHTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed
US-20080171440-A1 Pre-polishing treatment solution for interconnect substrate, polishing method, and method and apparatus for manufacturing interconnect substrate EBARA CORPORATION (JP) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MAPT 4018/4885ALDH1A1 290/4885GAA 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.